NASDAQ:CNTB

Connect Biopharma Holdings American Depositary Shares Stock Forecast

etoro logo Buy CNTB
*Your capital is at risk
$2.14
-0.0600 (-2.73%)
At Close: Jul 24, 2026
AI Analysis AI Analysis of CNTB AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CNTB to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Connect Biopharma Holdings Ltd American stock price ended at $2.14 on Friday, after losing 2.73%
(Updated on Jul 24, 2026)

Sell candidate since Jul 20, 2026 Loss -2.73%

The Connect Biopharma Holdings Ltd American stock price fell by -2.73% on the last day (Friday, 24th Jul 2026) from $2.20 to $2.14. During the last trading day the stock fluctuated 5.48% from a day low at $2.10 to a day high of $2.22. The price has fallen in 5 of the last 10 days and is down by -14.74% for this period. Volume has increased on the last day by 87 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 323 thousand shares were bought and sold for approximately $692.29 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -7.33% during the next 3 months and, with a 90% probability hold a price between $1.76 and $2.43 at the end of this 3-month period.

CNTB Signals & Forecast

There are few to no technical positive signals at the moment. The Connect Biopharma Holdings Ltd American stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $2.24 and $2.23. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen -19.55%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Connect Biopharma Holdings Ltd American gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Connect Biopharma Holdings Ltd American stock

Connect Biopharma Holdings Ltd American finds support from accumulated volume at $2.12 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.115 between high and low, or 5.48%. For the last week, the stock has had daily average volatility of 5.65%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CNTB) For The Upcoming Trading Day Of Monday 27th

For the upcoming trading day on Monday, 27th we expect Connect Biopharma Holdings Limited American Depositary Shares to open at $2.15, and during the day (based on 14 day Average True Range), to move between $2.05 and $2.23, which gives a possible trading interval of +/-$0.186 (+/-9.10%) up or down from last closing price. If Connect Biopharma Holdings Limited American Depositary Shares takes out the full calculated possible swing range there will be an estimated 9.10% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.12 (0.93%) than the resistance at $2.19 (2.34%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Connect Biopharma Holdings Limited American Depositary Shares stock A Buy?

Connect Biopharma Holdings Ltd American holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.988 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 27, 2026 - $2.15 ( 0.545%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CNTB Performance

Trading levels for CNTB

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 2.27 5.92%
R2 2.22 3.87%
R1 2.20 2.60%
Price 2.14
S1 2.11 -1.51%
S2 2.08 -2.78%
S3 2.04 -4.83%

Accumulated Volume Support & Resistance Levels

Level Price
R3 2.66 24.30%
R2 2.38 11.21%
R1 2.19 2.34%
Price 2.14
S1 2.12 -0.93%
S2 2.08 -2.80%
S3 1.99 -7.01%

FAQ

What is the symbol for Connect Biopharma Holdings Limited American Depositary Shares Stock and on which exchange is it traded?
The symbol for Connect Biopharma Holdings Limited American Depositary Shares is CNTB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Connect Biopharma Holdings Limited American Depositary Shares Stock?
Connect Biopharma Holdings Ltd American holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Connect Biopharma Holdings Limited American Depositary Shares Stock?
Connect Biopharma Holdings Limited American Depositary Shares Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Connect Biopharma Holdings Limited American Depositary Shares Stock.

What's the current price of Connect Biopharma Holdings Limited American Depositary Shares Stock?
As of the end of day on the Jul 24, 2026, the price of an Connect Biopharma Holdings Limited American Depositary Shares (CNTB) share was $2.14.

What is the 52-week high and low for Connect Biopharma Holdings Limited American Depositary Shares Stock?
The 52-week high for Connect Biopharma Holdings Limited American Depositary Shares Stock is $3.82 and the 52-week low is $1.23.

What is the market capitalization of Connect Biopharma Holdings Limited American Depositary Shares Stock?
As of the Jul 24, 2026, the market capitalization of Connect Biopharma Holdings Limited American Depositary Shares is 134.743M.

When is the next earnings date for Connect Biopharma Holdings Limited American Depositary Shares?
The upcoming earnings date for Connect Biopharma Holdings Limited American Depositary Shares is Aug 12, 2026.
Click to get the best stock tips daily for free!
ABOUT CONNECT BIOPHARMA HOLDINGS LIMITED AMERICAN DEPOSITARY SHARES
Connect Biopharma Holdings American Depositary Shares
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for the treatment of inflammatory allergic diseases, such as atopic dermatitis, asthma, and chronic rhinosin...
GOLDEN STAR
Ticker Change Signal Date
KMT
$34.39
2.44% Jul 21
DHT
$17.31
6.59% Jul 13
NMRK
$15.02
2.46% Jun 24
JLL
$299.78
8.56% Jun 24
ROP
$331.60
10.78% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE